Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Oct;61(4):408-409.
doi: 10.1165/rcmb.2019-0119ED.

Preventing Glutaminolysis: A Potential Therapy for Pulmonary Fibrosis

Vincent Esguerra  1   2 , Yutong Zhao  1   2   3
Affiliations
Editorial

Preventing Glutaminolysis: A Potential Therapy for Pulmonary Fibrosis

Vincent Esguerra et al. Am J Respir Cell Mol Biol. 2019 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074. - PubMed
    1. Kolb M, Bonella F, Wollin L. Therapeutic targets in idiopathic pulmonary fibrosis. Respir Med. 2017;131:49–57. - PubMed
    1. Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE. Drug treatment of idiopathic pulmonary fibrosis: systematic review and network meta-analysis. Chest. 2016;149:756–766. - PubMed
    1. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet. 2012;380:680–688. - PubMed
    1. Cui H, Xie N, Jiang D, Banerjee S, Ge J, Sanders YY, et al. Inhibition of glutaminase 1 attenuates experimental pulmonary fibrosis. Am J Respir Cell Mol Biol. 2019;61:492–500. - PMC - PubMed